Stay updated on Elsubrutinib & Upadacitinib in SLE Clinical Trial
Sign up to get notified when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.

Latest updates to the Elsubrutinib & Upadacitinib in SLE Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new version dated 2023-06-27 updates multiple core sections including Study Status, Study Description, Arms and Interventions, Outcome Measures, Eligibility, Contacts/Locations, Document Section, and IPD Sharing.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedPage now includes an official operating-status notice and updates version to v3.2.0, replacing v3.1.0.SummaryDifference9%

- Check48 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The old revision tag was removed along with the 'Back to Top' element.SummaryDifference0.5%

- Check69 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.5%

- Check77 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while also removing specific location details such as state, country, and city information.SummaryDifference51%

Stay in the know with updates to Elsubrutinib & Upadacitinib in SLE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.